Search results for "chronic"

showing 10 items of 3309 documents

Update in the Percutaneous Management of Coronary Chronic Total Occlusions

2018

Percutaneous coronary intervention (PCI) for chronic total occlusions (CTOs) has been rapidly evolving during recent years. With improvement in equipment and techniques, high success rates can be achieved at experienced centers, although overall success rates remain low. Prospective, randomized-controlled data regarding optimal use and indications for CTO PCI remain limited. CTO PCI should be performed when the anticipated benefit exceeds the potential risk. New high-quality studies of the clinical outcomes and techniques of CTO PCI are needed, as is the expansion of expert centers and operators that can achieve excellent clinical outcomes in this challenging patient and lesion subgroup. In…

medicine.medical_specialtyPercutaneousbusiness.industryPotential riskmedicine.medical_treatmentTreatment outcomePercutaneous coronary intervention030204 cardiovascular system & hematologyCABG = coronary artery bypass grafting CTA = computed tomography angiography CTO = chronic total occlusion IVUS = intravascular ultrasound MACE = major adverse cardiac event(s) MT = medical therapy OMT = optimal medical therapy PCI = percutaneous coronary intervention03 medical and health sciencessurgical procedures operative0302 clinical medicineChronic diseaseCoronary occlusionConventional PCImedicinecardiovascular diseases030212 general & internal medicineCardiology and Cardiovascular MedicinebusinessProspective cohort studyIntensive care medicine
researchProduct

Utility of Intravascular Ultrasound in Percutaneous Revascularization of Chronic Total Occlusions

2016

Intravascular ultrasound has been used for >20 years to guide percutaneous coronary intervention in different subsets of coronary lesions. During the last decade, the interest in percutaneous coronary intervention for chronic total occlusion (CTO) has increased dramatically, leading to high success rates. Failure of guidewire crossing is the most common reason for failed CTO attempts. Certain angiographic features, such as blunt proximal CTO cap, tortuosity, heavy calcification, and lack of visibility of path in the distal vessel, increase procedural difficulty. A better understanding of the behavior of the guidewire within the CTO segment may represent a key issue to achieve successful …

medicine.medical_specialtyPercutaneousmedicine.diagnostic_testbusiness.industrymedicine.medical_treatmentPercutaneous coronary intervention030204 cardiovascular system & hematologyRevascularizationTotal occlusionSettore MED/11 - Malattie Dell'Apparato Cardiovascolare03 medical and health sciences0302 clinical medicineBluntInternal medicineCTO = chronic total occlusion DES = drug-eluting stents IVUS = intravascular ultrasound MACE = major adverse cardiac event(s) PCI = percutaneous coronary interventionIntravascular ultrasoundConventional PCImedicineCardiology030212 general & internal medicineRadiologyCardiology and Cardiovascular MedicinebusinessMace
researchProduct

Dorsal Root Ganglion Stimulation for Chronic Postoperative Pain Following Thoracic Surgery: A Pilot Study.

2021

Objectives Post-thoracotomy pain syndrome (PTPS) is defined as persistent pain following a thoracotomy and has an incidence of 21-61%. Dorsal root ganglion stimulation (DRG-S) is a form of neuromodulation that modulates pain signal transmission to the spinal cord. The aims of this study were to investigate the efficacy of DRG-S for the management of PTPS and to assess the role of thoracic paravertebral blocks (t-PVB) as a tool for prediction of success of DRG-S. Materials and methods In this prospective study, we included all patients undergoing thoracic surgery, with PTPS not responding to pharmacotherapy and treated with DRG-S from September 2018 to February 2019. t-PVB followed by a perc…

medicine.medical_specialtyPercutaneousmedicine.medical_treatmentPilot Projects03 medical and health sciences0302 clinical medicineGanglia SpinalmedicineHumansThoracotomyProspective StudiesProspective cohort studyPain Postoperativebusiness.industryIncidence (epidemiology)Chronic painThoracic SurgeryGeneral MedicineSpinal cordmedicine.diseaseAnesthesiology and Pain Medicinemedicine.anatomical_structureNeurologyCardiothoracic surgeryAnesthesiaNerve blockNeurology (clinical)Chronic Painbusiness030217 neurology & neurosurgeryNeuromodulation : journal of the International Neuromodulation SocietyREFERENCES
researchProduct

Inverse Relationships between Glomerular Filtration Rate and Left Ventricular Mass in Uncomplicated Arterial Hypertension

2007

medicine.medical_specialtyPharmacotherapybusiness.industryInternal medicineInternal MedicinemedicineCardiologyChronic renal insufficiencyCardiology and Cardiovascular MedicinebusinessLeft ventricular hypertrophymedicine.diseaseFiltration fractionHigh Blood Pressure & Cardiovascular Prevention
researchProduct

Effects Of Elastic Resistance Band Exercise On Older Women With Nonspecific Chronic Low Back Pain

2017

medicine.medical_specialtyPhysical medicine and rehabilitationbusiness.industrymedicinePhysical Therapy Sports Therapy and RehabilitationOrthopedics and Sports MedicinebusinessChronic low back painMedicine & Science in Sports & Exercise
researchProduct

Clinical conditions responsible for hyperviscosity and skin ulcers complications

2017

In this brief review, we have examined some clinical conditions that result to be associated to an altered hemorheological profile and at times accompanied by skin ulcers. This skin condition may be observed in patients with the following condtions, such as primary polycythemic hyperviscosity (polycythemia, thrombocytemia) treated with hydroxyurea, primary plasma hyperviscosity (multiple myeloma, cryoglobulinemia, cryofibrinogenemia, dysfibrinogenemia, and connective tissue diseases), primary sclerocythemic hyperviscosity (hereditary spherocytosis, thalassemia, and sickle cell disease). In addition, it may be present in patients with secondary hyperviscosity conditions such as diabetes mell…

medicine.medical_specialtyPhysiologyChronic venous insufficiencyBlood viscosityHyperviscosity syndromeCryofibrinogenemiaHyperviscosity030204 cardiovascular system & hematologyGastroenterologyHyperviscosity syndrome; blood viscosity; skin ulcers030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineskin ulcershemic and lymphatic diseasesPhysiology (medical)Internal medicineHyperviscosity syndromeSkin UlcermedicineHumansbusiness.industryHematologyCritical limb ischemiaSkin ulcermedicine.diseaseCryoglobulinemiablood viscositymedicine.symptomCardiology and Cardiovascular Medicinebusiness
researchProduct

Left ventricular hypertrophy: not so much determinant of renal outcome?

2011

medicine.medical_specialtyPhysiologyProportional hazards modelbusiness.industryChronic kidney diseases.Renal functionLeft ventricular hypertrophyLeft ventricular hypertrophymedicine.diseaseOutcome (game theory)Chronic diseaseInternal medicineInternal MedicinemedicineCardiologyCardiology and Cardiovascular Medicinebusiness
researchProduct

Macro and microrheological determinants in chronic renal failure

2016

medicine.medical_specialtyPhysiologybusiness.industryPhysiology (medical)medicineChronic renal failureHematologyMacroCardiology and Cardiovascular MedicineIntensive care medicinebusiness
researchProduct

Erythrocyte Ca2+ content and red cell membrane transverse fluidity gradient in a group of subjects with chronic renal failure (CRF)

1991

medicine.medical_specialtyPhysiologychemistry.chemical_elementHematologyCalciumBiologyRed cell membraneRed blood cellmedicine.anatomical_structureEndocrinologychemistryPhysiology (medical)Internal medicinemedicineChronic renal failureCardiology and Cardiovascular Medicine
researchProduct

Renal protection by antihypertensive drugs

1998

During the last few years there has been a renewed interest in blood-pressure (BP)-induced kidney damage, owing to a progressive increase in the incidence and prevalence of hypertension and vascular diseases as a cause of end-stage renal disease (ESRD). The need to prevent ESRD demands continued efforts so as to identify early those people with hypertension who are at risk and to provide them with effective antihypertensive therapy. This review analyses what is needed in terms of surrogate endpoints for monitoring kidney damage and what is known about the impact of antihypertensive treatments in reducing the BP burden on the kidney in non-diabetic subjects. Although glomerular filtration ra…

medicine.medical_specialtyPhysiologymedicine.drug_classRenal functionBlood PressureKidneyurologic and male genital diseasesEssential hypertensionNephropathyRisk FactorsInternal medicineInternal MedicinemedicineAlbuminuriaHumansAntihypertensive drugAntihypertensive AgentsKidneyProteinuriabusiness.industrySurrogate endpointmedicine.diseasefemale genital diseases and pregnancy complicationsEndocrinologymedicine.anatomical_structureHypertensionCardiologyKidney Failure ChronicMicroalbuminuriamedicine.symptomCardiology and Cardiovascular MedicinebusinessJournal of Hypertension
researchProduct